Cited by 382Nanoparticle-Based Drug DeliveryImmunotherapy and Immune ResponsesRNA Interference and Gene Delivery

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Ishida, Tatsuhiro, Wang, XinYu, Shimizu, Taro, Nawata, Kosuke, Kiwada, Hiroshi·2007·Journal of Controlled Release

DOI 10.1016/j.jconrel.2007.05.015

Open this paper in CoChat — free account

Abstract

We recently reported that intravenous injections of "empty" PEGylated liposomes without encapsulated or surface coupled proteins elicit a PEG-specific IgM response in rats. In the present study, simultaneous weak anti-PEG IgG and strong anti-PEG IgM responses were detected following intravenous injections of "empty" PEGylated liposomes. The pattern of immune response appears to differ from the classic primary response against T cell-dependent (TD) antigens. The anti-PEG IgM response was detected in T-cell deficient nude BALB/c mice following intravenous injection of "empty" PEGylated liposomes, suggesting that "empty" PEGylated liposomes initiate the immune response against PEG in a T cell-independent manner. In vitro splenic lymphocytes-proliferation assay indicated that TNP-LPS, a typical type 1 T cell-independent (TI) antigen (TI-1 antigen), significantly primed the proliferation, while TNP-Ficoll, a typical type 2 TI antigen (TI-2 antigen), and "empty" PEGylated liposomes did not prime any proliferation under these experimental conditions. In addition, in splenic marginal zone (MZ) B-cell-depleted rats, the anti-PEG IgM response was diminished, while the immune reactions against TNP-BSA (a TD antigen) and TNP-LPS (TI-1 antigen) were not diminished. These results demonstrate that "empty" PEGylated liposomes may promote the immune response against PEG as a result of priming the activation of MZ B cells, as TI-2 antigen promotes a specific IgM response. In conclusion, although the mechanistic details behind the immune reaction against "empty" PEGylated liposomes are not yet clear, the liposomes elicit an anti-PEG IgM response in a T cell-independent manner and appear to be a TI-2 antigen, and splenic MZ B cells may be essential for the immune response against "empty" PEGylated liposomes.

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2007.05.015

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
Allen, T. M., Hansen, C., Martin, F., Redemann, C. T., & Yau‐Young, A. O. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,392
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 987
T Cell-Independent Antigens Type 2
Mond, J. J., Lees, A., & Snapper, C. M. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.003255 · Cited by 833
Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 606
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 558
Self-citation
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times
Lasiç, D. D., Martin, F. J., Gabizón, A., Huang, S. K., & Papahadjopoulos, D. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90162-2 · Cited by 545
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles
Senior, J. H., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity
Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Jr., Trubetskoy, V. S., Herron, J. N., & Gentry, C. A. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90003-5 · Cited by 466

Show all 45 references

Research works printed but not linked: 1

Li, 2001, Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes, Vaccine, 20, 148, 10.1016/S0264-410X(01)00277-8 · DOI

Sorted by citations

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging
Lane, L. A., Qian, X., & Nie, S. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00265 · Cited by 881
Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 856
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Self-citation
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696
Self-citation
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 711
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 744
Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 614
Recent advancements in liposome technology
Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 611
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 569
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 545
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 526
Nanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M. A., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 521
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 515
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 496
Self-citation
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products
Ibrahim, M. Y., Ramadan, E., Elsadek, N. E., Emam, S. E., Shimizu, T., Ando, H., Ishima, Y., El-Garhy, O. H., Sarhan, H. A., Hussein, A. K., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.031 · Cited by 481
Self-citation
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N. K., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 468
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 479
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 493
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415
Immunological and Toxicological Considerations for the Design of Liposomes
Inglut, C. T., Sorrin, A. J., Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H., & Huang, H. (2020) · Nanomaterials · doi:10.3390/nano10020190 · Cited by 384
Questioning the use of PEGylation for drug delivery
Verhoef, J. J. F., & Anchordoquy, T. J. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0176-5 · Cited by 346
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 344
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A. A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07522 · Cited by 346
Nanoparticle Toxicology
Yang, W., Wang, L., Mettenbrink, E. M., DeAngelis, P. L., & Wilhelm, S. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032320-110338 · Cited by 366
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00174 · Cited by 351
Material properties in complement activation
Moghimi, S. M., Andersen, A. J., Ahmadvand, D., Wibroe, P. P., Andresen, T. L., & Hunter, A. C. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.002 · Cited by 280
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
Cataldi, M., Vigliotti, C., Mosca, T., Cammarota, M., & Capone, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061249 · Cited by 280
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications
Luo, Y.-H., Chang, L. W., & Lin, P. (2015) · BioMed Research International · doi:10.1155/2015/143720 · Cited by 261
A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery
Chai, Z., Hu, X., Wei, X., Zhan, C., Lu, L., Jiang, K., Su, B., Ruan, H., Ran, D., Fang, R. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.027 · Cited by 253
Nonviral methods for siRNA delivery
Gao, K., & Huang, L. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800134q · Cited by 244
Poly Ethylene Glycol (PEG)‐Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review
Wang, Z., Ye, Q., Yu, S., & Akhavan, B. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300105 · Cited by 249
Co-delivery of drugs and plasmid DNA for cancer therapy
Teo, P. Y., Cheng, W., Hedrick, J. L., & Yang, Y. Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.014 · Cited by 231
PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production
Suzuki, T., Suzuki, Y., Hihara, T., Kubara, K., Kondo, K., Hyodo, K., Yamazaki, K., Ishida, T., & Ishihara, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119792 · Cited by 227
Self-citation
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Jeong, M., Lee, Y., Park, J., Jung, H., & Lee, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114990 · Cited by 232
Biomimetic O2-Evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor
Gao, S., Zheng, P., Li, Z., Feng, X., Yan, W., Chen, S., Guo, W., Liu, D., Yang, X., Wang, S., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.007 · Cited by 214
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
Mima, Y., Hashimoto, Y., Shimizu, T., Kiwada, H., & Ishida, T. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00144 · Cited by 213
Self-citation
Antitumor Platelet‐Mimicking Magnetic Nanoparticles
Rao, L., Bu, L., Meng, Q., Cai, B., Deng, W., Li, A., Li, K., Guo, S., Zhang, W., Liu, W., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604774 · Cited by 211
CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics
Xu, L., & Anchordoquy, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22243 · Cited by 209
Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.005 · Cited by 214
Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review
Shiraishi, K., & Yokoyama, M. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1590126 · Cited by 209
Micelles based on HPMA copolymers☆
Talelli, M., Rijcken, C. J. F., van Nostrum, C. F., Storm, G., & Hennink, W. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.029 · Cited by 211
Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design
Buyens, K., Smedt, S. C. D., Braeckmans, K., Demeester, J., Peeters, L., van Grunsven, L. A., du Jeu, X. D. M., Sawant, R. R., Torchilin, V. P., Farkasova, K., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.009 · Cited by 207
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., Yuki, K., Tanaka, K., Takenaga, M., Igarashi, R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9943-x · Cited by 196
Self-citation
Smart chemistry in polymeric nanomedicine
Tong, R., Tang, L., Ma, L., Tu, C., Baumgartner, R., & Cheng, J. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00133h · Cited by 195
Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery
Raemdonck, K., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60299k · Cited by 192
Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges
Komin, A., Russell, L. M., Hristova, K. A., & Searson, P. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.002 · Cited by 193
Role of the methoxy group in immune responses to mPEG-protein conjugates
Sherman, M. R., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Saifer, M. G. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200551b · Cited by 185
Liposome-based delivery of biological drugs
Magar, K. T., Boafo, G. F., Li, X., Chen, Z., & He, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.020 · Cited by 189
Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production
Yang, W. M., Liu, S., Bai, T., Keefe, A. J., Zhang, L., Ella‐Menye, J., Li, Y., & Jiang, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.02.004 · Cited by 186
Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells
Zhao, L., Xu, Y., Akasaka, T., Abe, S., Komatsu, N., Watari, F., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.041 · Cited by 182
In vivo delivery of RNAi with lipid-based nanoparticles
Huang, L., & Liu, Y. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124709 · Cited by 174
Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells
Ou, H., Cheng, T., Zhang, Y., Liu, J., Ding, Y., Zhen, J., Shen, W., Xu, Y., Yang, W., Niu, P., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.034 · Cited by 173
Protein Cages: From Fundamentals to Advanced Applications
Edwardson, T. G. W., Levasseur, M. D., Tetter, S., Steinauer, A., Hori, M., & Hilvert, D. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00877 · Cited by 171
Designer lipids for drug delivery: From heads to tails
Kohli, A. G., Kierstead, P. H., Venditto, V. J., Walsh, C. L., & Szoka, F. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.047 · Cited by 168
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Lubich, C., Allacher, P., de la Rosa, M., Bauer, A., Prenninger, T., Horling, F. M., Siekmann, J., Oldenburg, J., Scheiflinger, F., & Reipert, B. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1961-x · Cited by 167
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
Ichihara, M., Shimizu, T., Imoto, A., Hashiguchi, Y., Uehara, Y., Ishida, T., & Kiwada, H. (2010) · Pharmaceutics · doi:10.3390/pharmaceutics3010001 · Cited by 157
Self-citation
Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics
Date, T., Nimbalkar, V., Kamat, J., Mittal, A., Mahato, R. I., & Chitkara, D. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.016 · Cited by 153
Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting
Khoshnejad, M., Parhiz, H., Shuvaev, V. V., Dmochowski, I. J., & Muzykantov, V. R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.042 · Cited by 152
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Bevers, S., Kooijmans, S. A. A., van de Velde, E., Evers, M. J. W., Seghers, S., Gitz-Francois, J. J., van Kronenburg, N. C. H., Fens, M. H. A. M., Mastrobattista, E., Hassler, L., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.007 · Cited by 148
T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes
Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 143
Self-citation
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon
Shiraishi, K., Hamano, M., Ma, H., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., & Yokoyama, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.016 · Cited by 141
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 141
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
La-Beck, N. M., Islam, M. R., & Markiewski, M. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603039 · Cited by 139
Lipid-Based Nanoparticles in The Systemic Delivery of siRNA
Lin, Q., Chen, J., Zhang, Z., & Zheng, G. (2013) · Nanomedicine · doi:10.2217/nnm.13.192 · Cited by 133
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Rijkers, G. T., Weterings, N., Obregón‐Henao, A., Dutt, T., Dutt, T. S., van Overveld, F. J., & Henao-Tamayo, M. I. (2021) · Vaccines · doi:10.3390/vaccines9080848 · Cited by 139
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Hu, M., Li, X., You, Z., Cai, R., & Chen, C. (2023) · Advanced Materials · doi:10.1002/adma.202303266 · Cited by 142
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo
Grenier, P., Viana, I. M. D. O., Lima, E. M., & Bertrand, N. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.022 · Cited by 133
Cell-based drug delivery systems and their in vivo fate
Yang, L., Yang, Y., Chen, Y., Xu, Y., & Peng, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114394 · Cited by 131
Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients
Miao, G., He, Y., Lai, K., Zhao, Y. D., He, P., Tan, G., & Wang, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.003 · Cited by 135
Self-citation
Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug
Saadati, R., Dadashzadeh, S., Abbasian, Z., & Soleimanjahi, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0934-y · Cited by 127
Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
Chen, E., Chen, B., Su, Y.-C., Chang, Y., Cheng, T., Barenholz, Y., & Roffler, S. R. (2020) · ACS Nano · doi:10.1021/acsnano.9b07218 · Cited by 126
Protein corona and exosomes: new challenges and prospects
Heidarzadeh, M., Zarebkohan, A., Rahbarghazi‬, R., & Sokullu, E. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01089-1 · Cited by 140
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling
Moss, D. M., & Siccardi, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12604 · Cited by 132
Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
Self-citation
Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
Lila, A. S. A., Nawata, K., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.059 · Cited by 125
Self-citation
The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats
Ishida, T., Kashima, S., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.009 · Cited by 125
Self-citation
Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions
Szebeni, J., & Moghimi, S. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100902792855 · Cited by 128
Hyperbranched PEI with Various Oligosaccharide Architectures: Synthesis, Characterization, ATP Complexation, and Cellular Uptake Properties
Appelhans, D., Komber, H., Quadir, M., Richter, S., Schwarz, S., van der Vlist, J., Aigner, A. M., Müller, M., Loos, K., Seidel, J., et al. (2009) · Biomacromolecules · doi:10.1021/bm801310d · Cited by 124
Rational Design of Polyphenol-Poloxamer Nanovesicles for Targeting Inflammatory Bowel Disease Therapy
Wang, X., Yan, J., Wang, L., Pan, D., Yang, R., Xu, Y., Sheng, J., Huang, Q., Zhao, H., & Yang, M. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b01173 · Cited by 122
Self-citation
Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery
Martinez, J. O., Molinaro, R., Hartman, K. A., Boada, C., Sukhovershin, R. A., Rosa, E. D., Kuri, D., Zhang, S., Evangelopoulos, M., Carter, A. M., et al. (2018) · Theranostics · doi:10.7150/thno.22078 · Cited by 116
Nanoparticle Surface Functionality Dictates Cellular and Systemic Toxicity
Saei, A. A., Yazdani, M., Lohse, S. E., Bakhtiary, Z., Serpooshan, V., Ghavami, M., Asadian, M., Mashaghi, S., Dreaden, E. C., Mashaghi, A., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b01979 · Cited by 116
Protein PEPylation: A New Paradigm of Protein–Polymer Conjugation
Hou, Y., & Lu, H. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00236 · Cited by 112
The Art of PEGylation: From Simple Polymer to Sophisticated Drug Delivery System
Makharadze, D., del Valle, L. J., Katsarava, R. D., & Puiggalı́, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073102 · Cited by 122
Photoactivated Composite Biomaterial for Soft Tissue Restoration in Rodents and in Humans
Hillel, A. T., Unterman, S. A., Nahas, Z., Reid, B., Coburn, J. M., Axelman, J., Chae, J. J., Guo, Q., Trow, R., Thomas, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002331 · Cited by 109
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs
Szebeni, J., & Storm, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.177 · Cited by 107
Cancer Cell-Derived, Drug-Loaded Nanovesicles Induced by Sulfhydryl-Blocking for Effective and Safe Cancer Therapy
Ingato, D., Edson, J. A., Zakharian, M., & Kwon, Y. J. (2018) · ACS Nano · doi:10.1021/acsnano.8b05377 · Cited by 108
Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Guo, Q., Wang, S., Xu, R., Tang, Y., & Xia, X. (2024) · RSC Advances · doi:10.1039/d4ra01026d · Cited by 108
Polyethylene glycol immunogenicity in nanomedicine
Chen, Y., Su, Y.-C., & Roffler, S. R. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00321-6 · Cited by 118
Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined
Wang, H., Ding, T., Guan, J., Liu, X., Wang, J., Jin, P., Hou, S., Lu, W., Qian, J., Wang, W., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02821 · Cited by 102
Engineered metal based nanoparticles and innate immunity
Petrarca, C., Clemente, E., Amato, V., Pedata, P., Sabbioni, E., Bernardini, G., Iavicoli, I., Cortese, S., Niu, Q. L., Otsuki, T., et al. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0020-1 · Cited by 108
A facile and regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles using click chemistry
Kumar, D., Reddy, V. B., & Varma, R. S. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.02.107 · Cited by 101
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach
Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 125
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG
McSweeney, M. D., Price, L., Wessler, T., Ciociola, E. C., Herity, L. B., Piscitelli, J. A., DeWalle, A. C., Harris, T. N., Chan, A. K. P., Saw, R. S., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.017 · Cited by 99
Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy
Liu, M., Li, J., Zhao, D., Yan, N. J., Zhang, H., Liu, M., Tang, X., Hu, Y., Ding, J., Zhang, N., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121415 · Cited by 100

Authors: Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H.
Affiliations: Tokushima University (JP)
Corresponding author: Kiwada, Hiroshi
ORCID: Ishida, Tatsuhiro
Shimizu, Taro
Venue: Journal of Controlled Release
Publisher: Elsevier BV
Published: 2007-10
Volume: 122
Issue: 3
Pages: 349-355
ISSN: 0168-3659 (ISSN-L)
DOI: 10.1016/j.jconrel.2007.05.015
OpenAlex: W2087167636
Cited by: 382
References: 45
Citations by year: 2026: 13 · 2025: 20 · 2024: 14 · 2023: 28 · 2022: 20 · 2021: 23 · 2020: 25 · 2019: 13 · 2018: 32 · 2017: 22 · 2016: 24 · 2015: 29 · 2014: 24 · 2013: 29 · 2012: 25
FWCI: 4.91
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Controlled Release (publishedVersion)
PubMed (publishedVersion)
Funders: Kao Foundation for Arts and Sciences
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: PEGylated liposomes, T cell-independent immunity, marginal zone B cells, nude mice, TNP-LPS, TNP-Ficoll, splenocyte proliferation, intravenous injection
MeSH terms: Animals, Antigens, T-Independent, Cyclophosphamide, Immunoglobulin G, Immunoglobulin M, Injections, Intravenous, Liposomes, Male, Mice, Inbred BALB C, Mice, Nude, Polyethylene Glycols, Spleen, T-Lymphocytes, Rats, Wistar, Cell Proliferation, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks